A Nutritional Intervention for Migraines-2
NCT01699009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2015-10-20
Summary
The purpose of the study is to assess whether, in individuals with migraines, a low-fat, vegan diet improves pain more effectively than a control supplement or a placebo. The principal measures are pain as measured by Visual Analog Scale (VAS) and the change in migraines frequency. The study duration is 36 weeks.This study also tests that a low fat, plant-based (vegan) diet free of foods commonly identified as triggers improves mood, using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), and the Beck Depression Inventory II (BDI-II).
Conditions
- Migraines
Interventions
- OTHER
-
Plant based diet
- OTHER
-
an unrestricted diet
Sponsors & Collaborators
-
Physicians Committee for Responsible Medicine
lead OTHER
Principal Investigators
-
Neal Barnard, MD · Physicians Committee for Responsible Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
Nutrition for Chronic Daily Headache
NCT01157208 ·Status: COMPLETED ·Phase: NA
-
Ketone for Migraine Prevention
NCT05085483 ·Status: COMPLETED ·Phase: NA
-
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611 ·Status: COMPLETED ·Phase: NA
-
Neuro-Complex & Multi Supplements for Migraine Prevention
NCT07015411 ·Status: RECRUITING ·Phase: NA
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
NCT00660192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines
NCT00690716 ·Status: COMPLETED ·Phase: PHASE2
-
Mind Body Intervention for Chronic Migraine Headaches
NCT06690060 ·Status: RECRUITING ·Phase: NA
-
Acute Stress Response in Migraine Sufferers
NCT03099070 ·Status: TERMINATED ·Phase: NA
-
KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs
NCT05313503 ·Status: UNKNOWN ·Phase: NA
-
Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine
NCT04553445 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine
NCT01695460 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
NCT01617941 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of LY2951742 in Participants With Migraine
NCT01625988 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of a Drug and Placebo in the Prevention of Migraine Headaches
NCT01122381 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study
NCT02901756 ·Status: COMPLETED
-
Migraine and CVD Risk in Women
NCT03081390 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Migraine and Homeostasis:What Can we Learn From Glucose
NCT03097536 ·Status: TERMINATED ·Phase: NA
-
Psilocybin for the Treatment of Migraine Headache
NCT03341689 ·Status: COMPLETED ·Phase: PHASE1
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
Th Effect of Ketogenic Metabolic Nutritional Pattern on High-frequency Episodic Migraine (EMIKETO)
NCT04360148 ·Status: UNKNOWN ·Phase: NA
-
Brief Interventions in Chronic Migraine
NCT05979337 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
NCT04211454 ·Status: WITHDRAWN
-
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
NCT02163993 ·Status: COMPLETED ·Phase: PHASE2